Clinical trial

Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue

NCT02645175

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE2

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2016-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Fatigueunresolved

Interventions

TW1025DIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Meriyana Bio Inc.lead sponsor

US Oncology Researchcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02645175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.